
Biomedical Textile Market by Fiber Manager (Biodegradable Fiber, Non-Biodegradable Fiber), Fabric Type (Hollow Fabric, Knitted & Braided Fabric, Non-Woven Fabric), Application - Global Forecast 2023-2030
Description
Biomedical Textile Market by Fiber Manager (Biodegradable Fiber, Non-Biodegradable Fiber), Fabric Type (Hollow Fabric, Knitted & Braided Fabric, Non-Woven Fabric), Application - Global Forecast 2023-2030
The Biomedical Textile Market is projected to reach USD 20.91 billion by 2030 from USD 11.75 billion in 2022, at a CAGR of 7.47% during the forecast period.
Market Segmentation & Coverage:
This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Biomedical Textile Market.
- Based on Fiber Manager, market is studied across Biodegradable Fiber and Non-Biodegradable Fiber. The Biodegradable Fiber is further studied across Chitin and Collagen. The Non-Biodegradable Fiber is further studied across Cotton, Polyamide, Polyester, Polypropylene & Polyethylene, Polytetrafluoroethylene, Polyurethane, and Viscose. The Biodegradable Fiber is projected to witness significant market share during forecast period.
- Based on Fabric Type, market is studied across Hollow Fabric, Knitted & Braided Fabric, Non-Woven Fabric, and Woven Fabric. The Knitted & Braided Fabric is projected to witness significant market share during forecast period.
- Based on Application, market is studied across Extracorporeal Devices, Implantable, Non-Implantable, and Surgical Sutures. The Implantable is further studied across Dental Prosthesis, Hard Tissue Implants, Soft Tissue Implants, and Vascular Devices. The Implantable is projected to witness significant market share during forecast period.
- Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.
The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix is an indispensable tool for assessing the Biomedical Textile Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.
Market Share Analysis:
The Market Share Analysis offers invaluable insights into the vendor landscape Biomedical Textile Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.
Key Company Profiles:
The report delves into recent significant developments in the Biomedical Textile Market, highlighting leading vendors and their innovative profiles. These include ARAN BIOMEDICAL, Asahi Kasei Corporation, ATEX Technologies, Inc., B. Braun Melsungen AG, Bally Ribbon Mills, BSN Medical by Svenska Cellulosa Aktiebolaget SCA, Cardinal Health, Inc, Confluent Medical Technologies, CORTLAND BIOMEDICAL by Tufropes Pvt Ltd., Integra LifeSciences Corporation, J-Pac, LLC, Johnson & Johnson Services Inc., Koninklijke DSM N.V., Medline Industries, LP, Medtronic PLC, Meister & Cie AG, PAUL HARTMANN AG, Poly-Med Incorporated, Schouw & Co AS, Secant Group LLC, Shieldex by Statex Production and Sales GmbH, SurgicalMesh, Swicofil AG, The Freudenberg Group, and W. L. Gore & Associates, Inc..
The report offers valuable insights on the following aspects:
- Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
- Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
- Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
- Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
- Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.
- What is the market size and forecast for the Biomedical Textile Market?
- Which products, segments, applications, and areas hold the highest investment potential in the Biomedical Textile Market?
- What is the competitive strategic window for identifying opportunities in the Biomedical Textile Market?
- What are the latest technology trends and regulatory frameworks in the Biomedical Textile Market?
- What is the market share of the leading vendors in the Biomedical Textile Market?
- Which modes and strategic moves are suitable for entering the Biomedical Textile Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
189 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Biomedical Textile Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Increasing number of accidents and surgeries
- 5.1.1.2. Rapid growth in the aging population, and increased healthcare expenditure
- 5.1.1.3. Demand for TAVR incorporated textiles to prevent abrasion and encourage tissue growth
- 5.1.2. Restraints
- 5.1.2.1. Complex raw material and heavy investments
- 5.1.3. Opportunities
- 5.1.3.1. Advancements in surgical robotics resulting for close collaboration between textile developers and medical device OEMs
- 5.1.3.2. Advancements in smart biomedical textiles
- 5.1.4. Challenges
- 5.1.4.1. Lack of trained skilled manpower with interdisciplinary knowledge
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of COVID-19
- 5.5. Cumulative Impact of Russia-Ukraine Conflict
- 5.6. Cumulative Impact of High Inflation
- 5.7. Porter’s Five Forces Analysis
- 5.7.1. Threat of New Entrants
- 5.7.2. Threat of Substitutes
- 5.7.3. Bargaining Power of Customers
- 5.7.4. Bargaining Power of Suppliers
- 5.7.5. Industry Rivalry
- 5.8. Value Chain & Critical Path Analysis
- 5.9. Regulatory Framework
- 5.10. Client Customization
- 6. Biomedical Textile Market, by Fiber Manager
- 6.1. Introduction
- 6.2. Biodegradable Fiber
- 6.3.1. Chitin
- 6.3.2. Collagen
- 6.3. Non-Biodegradable Fiber
- 6.4.1. Cotton
- 6.4.2. Polyamide
- 6.4.3. Polyester
- 6.4.4. Polypropylene & Polyethylene
- 6.4.5. Polytetrafluoroethylene
- 6.4.6. Polyurethane
- 6.4.7. Viscose
- 7. Biomedical Textile Market, by Fabric Type
- 7.1. Introduction
- 7.2. Hollow Fabric
- 7.3. Knitted & Braided Fabric
- 7.4. Non-Woven Fabric
- 7.5. Woven Fabric
- 8. Biomedical Textile Market, by Application
- 8.1. Introduction
- 8.2. Extracorporeal Devices
- 8.3. Implantable
- 8.4.1. Dental Prosthesis
- 8.4.2. Hard Tissue Implants
- 8.4.3. Soft Tissue Implants
- 8.4.4. Vascular Devices
- 8.4. Non-Implantable
- 8.5. Surgical Sutures
- 9. Americas Biomedical Textile Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
- 10. Asia-Pacific Biomedical Textile Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
- 11. Europe, Middle East & Africa Biomedical Textile Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
- 12. Competitive Landscape
- 12.1. FPNV Positioning Matrix
- 12.2. Market Share Analysis, By Key Player
- 12.3. Competitive Scenario Analysis, By Key Player
- 13. Competitive Portfolio
- 13.1. Key Company Profiles
- 13.1.1. ARAN BIOMEDICAL
- 13.1.2. Asahi Kasei Corporation
- 13.1.3. ATEX Technologies, Inc.
- 13.1.4. B. Braun Melsungen AG
- 13.1.5. Bally Ribbon Mills
- 13.1.6. BSN Medical by Svenska Cellulosa Aktiebolaget SCA
- 13.1.7. Cardinal Health, Inc
- 13.1.8. Confluent Medical Technologies
- 13.1.9. CORTLAND BIOMEDICAL by Tufropes Pvt Ltd.
- 13.1.10. Integra LifeSciences Corporation
- 13.1.11. J-Pac, LLC
- 13.1.12. Johnson & Johnson Services Inc.
- 13.1.13. Koninklijke DSM N.V.
- 13.1.14. Medline Industries, LP
- 13.1.15. Medtronic PLC
- 13.1.16. Meister & Cie AG
- 13.1.17. PAUL HARTMANN AG
- 13.1.18. Poly-Med Incorporated
- 13.1.19. Schouw & Co AS
- 13.1.20. Secant Group LLC
- 13.1.21. Shieldex by Statex Production and Sales GmbH
- 13.1.22. SurgicalMesh
- 13.1.23. Swicofil AG
- 13.1.24. The Freudenberg Group
- 13.1.25. W. L. Gore & Associates, Inc.
- 13.2. Key Product Portfolio
- 14. Appendix
- 14.1. Discussion Guide
- 14.2. License & Pricing
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.